ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Olmesartan API Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-4A9912
Home | Market Reports | Health| Pharmacy
Global Olmesartan API Market Research Report 2022
BUY CHAPTERS

Global Olmesartan API Market Research Report 2024

Code: QYRE-Auto-4A9912
Report
March 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Interquim
Biophore India Pharmaceuticals
Summit Pharmaceuticals Europe
Sanofi
Zhejiang Tianyu Pharmaceutical
Teva API
Zhejiang Huahai Pharmaceutical
Cadila Pharmaceuticals
Unimark Remedies
Vasudha Pharma
Macleods Pharmaceuticals
Mylan NV
Coba Pharma
Acura Labs
Euro API
Jai Radhe
Octavius Pharma Pvt. Ltd
Zeon Health lndustries
Glenmark Pharmaceuticals Europe
Verdant Pharma
Hubei Yitai Pharmaceuticals
Ulkar Kimya
Venkata Narayana Active Ingredients

Olmesartan API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Olmesartan API Market

Olmesartan API Market

The global Olmesartan API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Olmesartan API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olmesartan API.

Report Scope

The Olmesartan API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Olmesartan API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Olmesartan API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Olmesartan API Market Report

Report Metric Details
Report Name Olmesartan API Market
CAGR 5%
Segment by Type
  • Purity 99%
  • Purity > 99%
Segment by Application
  • Tablet Products
  • Capsule Products
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Coba Pharma, Acura Labs, Interquim, Euro API, Biophore India Pharmaceuticals, Jai Radhe, Summit Pharmaceuticals Europe, Octavius Pharma Pvt. Ltd, Zeon Health lndustries, Sanofi, Glenmark Pharmaceuticals Europe, Verdant Pharma, Hubei Yitai Pharmaceuticals, Ulkar Kimya, Zhejiang Tianyu Pharmaceutical, Teva API, Zhejiang Huahai Pharmaceutical, Venkata Narayana Active Ingredients, Cadila Pharmaceuticals, Unimark Remedies, Vasudha Pharma, Macleods Pharmaceuticals, Mylan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Olmesartan API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Olmesartan API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Olmesartan API Market report?

Ans: The main players in the Olmesartan API Market are Coba Pharma, Acura Labs, Interquim, Euro API, Biophore India Pharmaceuticals, Jai Radhe, Summit Pharmaceuticals Europe, Octavius Pharma Pvt. Ltd, Zeon Health lndustries, Sanofi, Glenmark Pharmaceuticals Europe, Verdant Pharma, Hubei Yitai Pharmaceuticals, Ulkar Kimya, Zhejiang Tianyu Pharmaceutical, Teva API, Zhejiang Huahai Pharmaceutical, Venkata Narayana Active Ingredients, Cadila Pharmaceuticals, Unimark Remedies, Vasudha Pharma, Macleods Pharmaceuticals, Mylan

What are the Application segmentation covered in the Olmesartan API Market report?

Ans: The Applications covered in the Olmesartan API Market report are Tablet Products, Capsule Products, Others

What are the Type segmentation covered in the Olmesartan API Market report?

Ans: The Types covered in the Olmesartan API Market report are Purity 99%, Purity > 99%

1 Olmesartan API Market Overview
1.1 Product Overview and Scope of Olmesartan API
1.2 Olmesartan API Segment by Type
1.2.1 Global Olmesartan API Market Value Comparison by Type (2024-2030)
1.2.2 Purity 99%
1.2.3 Purity > 99%
1.3 Olmesartan API Segment by Application
1.3.1 Global Olmesartan API Market Value by Application: (2024-2030)
1.3.2 Tablet Products
1.3.3 Capsule Products
1.3.4 Others
1.4 Global Olmesartan API Market Size Estimates and Forecasts
1.4.1 Global Olmesartan API Revenue 2019-2030
1.4.2 Global Olmesartan API Sales 2019-2030
1.4.3 Global Olmesartan API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Olmesartan API Market Competition by Manufacturers
2.1 Global Olmesartan API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Olmesartan API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Olmesartan API Average Price by Manufacturers (2019-2024)
2.4 Global Olmesartan API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Olmesartan API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Olmesartan API, Product Type & Application
2.7 Olmesartan API Market Competitive Situation and Trends
2.7.1 Olmesartan API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Olmesartan API Players Market Share by Revenue
2.7.3 Global Olmesartan API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Olmesartan API Retrospective Market Scenario by Region
3.1 Global Olmesartan API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Olmesartan API Global Olmesartan API Sales by Region: 2019-2030
3.2.1 Global Olmesartan API Sales by Region: 2019-2024
3.2.2 Global Olmesartan API Sales by Region: 2025-2030
3.3 Global Olmesartan API Global Olmesartan API Revenue by Region: 2019-2030
3.3.1 Global Olmesartan API Revenue by Region: 2019-2024
3.3.2 Global Olmesartan API Revenue by Region: 2025-2030
3.4 North America Olmesartan API Market Facts & Figures by Country
3.4.1 North America Olmesartan API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Olmesartan API Sales by Country (2019-2030)
3.4.3 North America Olmesartan API Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Olmesartan API Market Facts & Figures by Country
3.5.1 Europe Olmesartan API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Olmesartan API Sales by Country (2019-2030)
3.5.3 Europe Olmesartan API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Olmesartan API Market Facts & Figures by Country
3.6.1 Asia Pacific Olmesartan API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Olmesartan API Sales by Country (2019-2030)
3.6.3 Asia Pacific Olmesartan API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Olmesartan API Market Facts & Figures by Country
3.7.1 Latin America Olmesartan API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Olmesartan API Sales by Country (2019-2030)
3.7.3 Latin America Olmesartan API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Olmesartan API Market Facts & Figures by Country
3.8.1 Middle East and Africa Olmesartan API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Olmesartan API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Olmesartan API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Olmesartan API Sales by Type (2019-2030)
4.1.1 Global Olmesartan API Sales by Type (2019-2024)
4.1.2 Global Olmesartan API Sales by Type (2025-2030)
4.1.3 Global Olmesartan API Sales Market Share by Type (2019-2030)
4.2 Global Olmesartan API Revenue by Type (2019-2030)
4.2.1 Global Olmesartan API Revenue by Type (2019-2024)
4.2.2 Global Olmesartan API Revenue by Type (2025-2030)
4.2.3 Global Olmesartan API Revenue Market Share by Type (2019-2030)
4.3 Global Olmesartan API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Olmesartan API Sales by Application (2019-2030)
5.1.1 Global Olmesartan API Sales by Application (2019-2024)
5.1.2 Global Olmesartan API Sales by Application (2025-2030)
5.1.3 Global Olmesartan API Sales Market Share by Application (2019-2030)
5.2 Global Olmesartan API Revenue by Application (2019-2030)
5.2.1 Global Olmesartan API Revenue by Application (2019-2024)
5.2.2 Global Olmesartan API Revenue by Application (2025-2030)
5.2.3 Global Olmesartan API Revenue Market Share by Application (2019-2030)
5.3 Global Olmesartan API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Coba Pharma
6.1.1 Coba Pharma Corporation Information
6.1.2 Coba Pharma Description and Business Overview
6.1.3 Coba Pharma Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Coba Pharma Olmesartan API Product Portfolio
6.1.5 Coba Pharma Recent Developments/Updates
6.2 Acura Labs
6.2.1 Acura Labs Corporation Information
6.2.2 Acura Labs Description and Business Overview
6.2.3 Acura Labs Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Acura Labs Olmesartan API Product Portfolio
6.2.5 Acura Labs Recent Developments/Updates
6.3 Interquim
6.3.1 Interquim Corporation Information
6.3.2 Interquim Description and Business Overview
6.3.3 Interquim Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Interquim Olmesartan API Product Portfolio
6.3.5 Interquim Recent Developments/Updates
6.4 Euro API
6.4.1 Euro API Corporation Information
6.4.2 Euro API Description and Business Overview
6.4.3 Euro API Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Euro API Olmesartan API Product Portfolio
6.4.5 Euro API Recent Developments/Updates
6.5 Biophore India Pharmaceuticals
6.5.1 Biophore India Pharmaceuticals Corporation Information
6.5.2 Biophore India Pharmaceuticals Description and Business Overview
6.5.3 Biophore India Pharmaceuticals Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biophore India Pharmaceuticals Olmesartan API Product Portfolio
6.5.5 Biophore India Pharmaceuticals Recent Developments/Updates
6.6 Jai Radhe
6.6.1 Jai Radhe Corporation Information
6.6.2 Jai Radhe Description and Business Overview
6.6.3 Jai Radhe Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Jai Radhe Olmesartan API Product Portfolio
6.6.5 Jai Radhe Recent Developments/Updates
6.7 Summit Pharmaceuticals Europe
6.6.1 Summit Pharmaceuticals Europe Corporation Information
6.6.2 Summit Pharmaceuticals Europe Description and Business Overview
6.6.3 Summit Pharmaceuticals Europe Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Summit Pharmaceuticals Europe Olmesartan API Product Portfolio
6.7.5 Summit Pharmaceuticals Europe Recent Developments/Updates
6.8 Octavius Pharma Pvt. Ltd
6.8.1 Octavius Pharma Pvt. Ltd Corporation Information
6.8.2 Octavius Pharma Pvt. Ltd Description and Business Overview
6.8.3 Octavius Pharma Pvt. Ltd Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Octavius Pharma Pvt. Ltd Olmesartan API Product Portfolio
6.8.5 Octavius Pharma Pvt. Ltd Recent Developments/Updates
6.9 Zeon Health lndustries
6.9.1 Zeon Health lndustries Corporation Information
6.9.2 Zeon Health lndustries Description and Business Overview
6.9.3 Zeon Health lndustries Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zeon Health lndustries Olmesartan API Product Portfolio
6.9.5 Zeon Health lndustries Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sanofi Olmesartan API Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Glenmark Pharmaceuticals Europe
6.11.1 Glenmark Pharmaceuticals Europe Corporation Information
6.11.2 Glenmark Pharmaceuticals Europe Olmesartan API Description and Business Overview
6.11.3 Glenmark Pharmaceuticals Europe Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Glenmark Pharmaceuticals Europe Olmesartan API Product Portfolio
6.11.5 Glenmark Pharmaceuticals Europe Recent Developments/Updates
6.12 Verdant Pharma
6.12.1 Verdant Pharma Corporation Information
6.12.2 Verdant Pharma Olmesartan API Description and Business Overview
6.12.3 Verdant Pharma Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Verdant Pharma Olmesartan API Product Portfolio
6.12.5 Verdant Pharma Recent Developments/Updates
6.13 Hubei Yitai Pharmaceuticals
6.13.1 Hubei Yitai Pharmaceuticals Corporation Information
6.13.2 Hubei Yitai Pharmaceuticals Olmesartan API Description and Business Overview
6.13.3 Hubei Yitai Pharmaceuticals Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hubei Yitai Pharmaceuticals Olmesartan API Product Portfolio
6.13.5 Hubei Yitai Pharmaceuticals Recent Developments/Updates
6.14 Ulkar Kimya
6.14.1 Ulkar Kimya Corporation Information
6.14.2 Ulkar Kimya Olmesartan API Description and Business Overview
6.14.3 Ulkar Kimya Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Ulkar Kimya Olmesartan API Product Portfolio
6.14.5 Ulkar Kimya Recent Developments/Updates
6.15 Zhejiang Tianyu Pharmaceutical
6.15.1 Zhejiang Tianyu Pharmaceutical Corporation Information
6.15.2 Zhejiang Tianyu Pharmaceutical Olmesartan API Description and Business Overview
6.15.3 Zhejiang Tianyu Pharmaceutical Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Zhejiang Tianyu Pharmaceutical Olmesartan API Product Portfolio
6.15.5 Zhejiang Tianyu Pharmaceutical Recent Developments/Updates
6.16 Teva API
6.16.1 Teva API Corporation Information
6.16.2 Teva API Olmesartan API Description and Business Overview
6.16.3 Teva API Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Teva API Olmesartan API Product Portfolio
6.16.5 Teva API Recent Developments/Updates
6.17 Zhejiang Huahai Pharmaceutical
6.17.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.17.2 Zhejiang Huahai Pharmaceutical Olmesartan API Description and Business Overview
6.17.3 Zhejiang Huahai Pharmaceutical Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Zhejiang Huahai Pharmaceutical Olmesartan API Product Portfolio
6.17.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.18 Venkata Narayana Active Ingredients
6.18.1 Venkata Narayana Active Ingredients Corporation Information
6.18.2 Venkata Narayana Active Ingredients Olmesartan API Description and Business Overview
6.18.3 Venkata Narayana Active Ingredients Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Venkata Narayana Active Ingredients Olmesartan API Product Portfolio
6.18.5 Venkata Narayana Active Ingredients Recent Developments/Updates
6.19 Cadila Pharmaceuticals
6.19.1 Cadila Pharmaceuticals Corporation Information
6.19.2 Cadila Pharmaceuticals Olmesartan API Description and Business Overview
6.19.3 Cadila Pharmaceuticals Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Cadila Pharmaceuticals Olmesartan API Product Portfolio
6.19.5 Cadila Pharmaceuticals Recent Developments/Updates
6.20 Unimark Remedies
6.20.1 Unimark Remedies Corporation Information
6.20.2 Unimark Remedies Olmesartan API Description and Business Overview
6.20.3 Unimark Remedies Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Unimark Remedies Olmesartan API Product Portfolio
6.20.5 Unimark Remedies Recent Developments/Updates
6.21 Vasudha Pharma
6.21.1 Vasudha Pharma Corporation Information
6.21.2 Vasudha Pharma Olmesartan API Description and Business Overview
6.21.3 Vasudha Pharma Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Vasudha Pharma Olmesartan API Product Portfolio
6.21.5 Vasudha Pharma Recent Developments/Updates
6.22 Macleods Pharmaceuticals
6.22.1 Macleods Pharmaceuticals Corporation Information
6.22.2 Macleods Pharmaceuticals Olmesartan API Description and Business Overview
6.22.3 Macleods Pharmaceuticals Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Macleods Pharmaceuticals Olmesartan API Product Portfolio
6.22.5 Macleods Pharmaceuticals Recent Developments/Updates
6.23 Mylan
6.23.1 Mylan Corporation Information
6.23.2 Mylan Olmesartan API Description and Business Overview
6.23.3 Mylan Olmesartan API Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Mylan Olmesartan API Product Portfolio
6.23.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Olmesartan API Industry Chain Analysis
7.2 Olmesartan API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Olmesartan API Production Mode & Process
7.4 Olmesartan API Sales and Marketing
7.4.1 Olmesartan API Sales Channels
7.4.2 Olmesartan API Distributors
7.5 Olmesartan API Customers
8 Olmesartan API Market Dynamics
8.1 Olmesartan API Industry Trends
8.2 Olmesartan API Market Drivers
8.3 Olmesartan API Market Challenges
8.4 Olmesartan API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Interquim
Biophore India Pharmaceuticals
Summit Pharmaceuticals Europe
Sanofi
Zhejiang Tianyu Pharmaceutical
Teva API
Zhejiang Huahai Pharmaceutical
Cadila Pharmaceuticals
Unimark Remedies
Vasudha Pharma
Macleods Pharmaceuticals
Mylan NV
Coba Pharma
Acura Labs
Euro API
Jai Radhe
Octavius Pharma Pvt. Ltd
Zeon Health lndustries
Glenmark Pharmaceuticals Europe
Verdant Pharma
Hubei Yitai Pharmaceuticals
Ulkar Kimya
Venkata Narayana Active Ingredients
List of Tables
    Table 1. Global Olmesartan API Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Olmesartan API Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Olmesartan API Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Olmesartan API Sales (Tons) of Key Manufacturers (2019-2024)
    Table 5. Global Olmesartan API Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Olmesartan API Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Olmesartan API Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Olmesartan API Average Price (US$/Kg) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Olmesartan API, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Olmesartan API, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Olmesartan API, Product Type & Application
    Table 12. Global Key Manufacturers of Olmesartan API, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Olmesartan API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olmesartan API as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Olmesartan API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Olmesartan API Sales by Region (2019-2024) & (Tons)
    Table 18. Global Olmesartan API Sales Market Share by Region (2019-2024)
    Table 19. Global Olmesartan API Sales by Region (2025-2030) & (Tons)
    Table 20. Global Olmesartan API Sales Market Share by Region (2025-2030)
    Table 21. Global Olmesartan API Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Olmesartan API Revenue Market Share by Region (2019-2024)
    Table 23. Global Olmesartan API Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Olmesartan API Revenue Market Share by Region (2025-2030)
    Table 25. North America Olmesartan API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Olmesartan API Sales by Country (2019-2024) & (Tons)
    Table 27. North America Olmesartan API Sales by Country (2025-2030) & (Tons)
    Table 28. North America Olmesartan API Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Olmesartan API Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Olmesartan API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Olmesartan API Sales by Country (2019-2024) & (Tons)
    Table 32. Europe Olmesartan API Sales by Country (2025-2030) & (Tons)
    Table 33. Europe Olmesartan API Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Olmesartan API Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Olmesartan API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Olmesartan API Sales by Region (2019-2024) & (Tons)
    Table 37. Asia Pacific Olmesartan API Sales by Region (2025-2030) & (Tons)
    Table 38. Asia Pacific Olmesartan API Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Olmesartan API Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Olmesartan API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Olmesartan API Sales by Country (2019-2024) & (Tons)
    Table 42. Latin America Olmesartan API Sales by Country (2025-2030) & (Tons)
    Table 43. Latin America Olmesartan API Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Olmesartan API Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Olmesartan API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Olmesartan API Sales by Country (2019-2024) & (Tons)
    Table 47. Middle East & Africa Olmesartan API Sales by Country (2025-2030) & (Tons)
    Table 48. Middle East & Africa Olmesartan API Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Olmesartan API Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Olmesartan API Sales (Tons) by Type (2019-2024)
    Table 51. Global Olmesartan API Sales (Tons) by Type (2025-2030)
    Table 52. Global Olmesartan API Sales Market Share by Type (2019-2024)
    Table 53. Global Olmesartan API Sales Market Share by Type (2025-2030)
    Table 54. Global Olmesartan API Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Olmesartan API Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Olmesartan API Revenue Market Share by Type (2019-2024)
    Table 57. Global Olmesartan API Revenue Market Share by Type (2025-2030)
    Table 58. Global Olmesartan API Price (US$/Kg) by Type (2019-2024)
    Table 59. Global Olmesartan API Price (US$/Kg) by Type (2025-2030)
    Table 60. Global Olmesartan API Sales (Tons) by Application (2019-2024)
    Table 61. Global Olmesartan API Sales (Tons) by Application (2025-2030)
    Table 62. Global Olmesartan API Sales Market Share by Application (2019-2024)
    Table 63. Global Olmesartan API Sales Market Share by Application (2025-2030)
    Table 64. Global Olmesartan API Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Olmesartan API Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Olmesartan API Revenue Market Share by Application (2019-2024)
    Table 67. Global Olmesartan API Revenue Market Share by Application (2025-2030)
    Table 68. Global Olmesartan API Price (US$/Kg) by Application (2019-2024)
    Table 69. Global Olmesartan API Price (US$/Kg) by Application (2025-2030)
    Table 70. Coba Pharma Corporation Information
    Table 71. Coba Pharma Description and Business Overview
    Table 72. Coba Pharma Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 73. Coba Pharma Olmesartan API Product
    Table 74. Coba Pharma Recent Developments/Updates
    Table 75. Acura Labs Corporation Information
    Table 76. Acura Labs Description and Business Overview
    Table 77. Acura Labs Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 78. Acura Labs Olmesartan API Product
    Table 79. Acura Labs Recent Developments/Updates
    Table 80. Interquim Corporation Information
    Table 81. Interquim Description and Business Overview
    Table 82. Interquim Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 83. Interquim Olmesartan API Product
    Table 84. Interquim Recent Developments/Updates
    Table 85. Euro API Corporation Information
    Table 86. Euro API Description and Business Overview
    Table 87. Euro API Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 88. Euro API Olmesartan API Product
    Table 89. Euro API Recent Developments/Updates
    Table 90. Biophore India Pharmaceuticals Corporation Information
    Table 91. Biophore India Pharmaceuticals Description and Business Overview
    Table 92. Biophore India Pharmaceuticals Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 93. Biophore India Pharmaceuticals Olmesartan API Product
    Table 94. Biophore India Pharmaceuticals Recent Developments/Updates
    Table 95. Jai Radhe Corporation Information
    Table 96. Jai Radhe Description and Business Overview
    Table 97. Jai Radhe Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 98. Jai Radhe Olmesartan API Product
    Table 99. Jai Radhe Recent Developments/Updates
    Table 100. Summit Pharmaceuticals Europe Corporation Information
    Table 101. Summit Pharmaceuticals Europe Description and Business Overview
    Table 102. Summit Pharmaceuticals Europe Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 103. Summit Pharmaceuticals Europe Olmesartan API Product
    Table 104. Summit Pharmaceuticals Europe Recent Developments/Updates
    Table 105. Octavius Pharma Pvt. Ltd Corporation Information
    Table 106. Octavius Pharma Pvt. Ltd Description and Business Overview
    Table 107. Octavius Pharma Pvt. Ltd Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 108. Octavius Pharma Pvt. Ltd Olmesartan API Product
    Table 109. Octavius Pharma Pvt. Ltd Recent Developments/Updates
    Table 110. Zeon Health lndustries Corporation Information
    Table 111. Zeon Health lndustries Description and Business Overview
    Table 112. Zeon Health lndustries Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 113. Zeon Health lndustries Olmesartan API Product
    Table 114. Zeon Health lndustries Recent Developments/Updates
    Table 115. Sanofi Corporation Information
    Table 116. Sanofi Description and Business Overview
    Table 117. Sanofi Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 118. Sanofi Olmesartan API Product
    Table 119. Sanofi Recent Developments/Updates
    Table 120. Glenmark Pharmaceuticals Europe Corporation Information
    Table 121. Glenmark Pharmaceuticals Europe Description and Business Overview
    Table 122. Glenmark Pharmaceuticals Europe Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 123. Glenmark Pharmaceuticals Europe Olmesartan API Product
    Table 124. Glenmark Pharmaceuticals Europe Recent Developments/Updates
    Table 125. Verdant Pharma Corporation Information
    Table 126. Verdant Pharma Description and Business Overview
    Table 127. Verdant Pharma Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 128. Verdant Pharma Olmesartan API Product
    Table 129. Verdant Pharma Recent Developments/Updates
    Table 130. Hubei Yitai Pharmaceuticals Corporation Information
    Table 131. Hubei Yitai Pharmaceuticals Description and Business Overview
    Table 132. Hubei Yitai Pharmaceuticals Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 133. Hubei Yitai Pharmaceuticals Olmesartan API Product
    Table 134. Hubei Yitai Pharmaceuticals Recent Developments/Updates
    Table 135. Ulkar Kimya Corporation Information
    Table 136. Ulkar Kimya Description and Business Overview
    Table 137. Ulkar Kimya Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 138. Ulkar Kimya Olmesartan API Product
    Table 139. Ulkar Kimya Recent Developments/Updates
    Table 140. Zhejiang Tianyu Pharmaceutical Corporation Information
    Table 141. Zhejiang Tianyu Pharmaceutical Description and Business Overview
    Table 142. Zhejiang Tianyu Pharmaceutical Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 143. Zhejiang Tianyu Pharmaceutical Olmesartan API Product
    Table 144. Zhejiang Tianyu Pharmaceutical Recent Developments/Updates
    Table 145. Teva API Corporation Information
    Table 146. Teva API Description and Business Overview
    Table 147. Teva API Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 148. Teva API Olmesartan API Product
    Table 149. Teva API Recent Developments/Updates
    Table 150. Zhejiang Huahai Pharmaceutical Corporation Information
    Table 151. Zhejiang Huahai Pharmaceutical Description and Business Overview
    Table 152. Zhejiang Huahai Pharmaceutical Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 153. Zhejiang Huahai Pharmaceutical Olmesartan API Product
    Table 154. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
    Table 155. Venkata Narayana Active Ingredients Corporation Information
    Table 156. Venkata Narayana Active Ingredients Description and Business Overview
    Table 157. Venkata Narayana Active Ingredients Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 158. Venkata Narayana Active Ingredients Olmesartan API Product
    Table 159. Venkata Narayana Active Ingredients Recent Developments/Updates
    Table 160. Cadila Pharmaceuticals Corporation Information
    Table 161. Cadila Pharmaceuticals Description and Business Overview
    Table 162. Cadila Pharmaceuticals Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 163. Cadila Pharmaceuticals Olmesartan API Product
    Table 164. Cadila Pharmaceuticals Recent Developments/Updates
    Table 165. Unimark Remedies Corporation Information
    Table 166. Unimark Remedies Description and Business Overview
    Table 167. Unimark Remedies Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 168. Unimark Remedies Olmesartan API Product
    Table 169. Unimark Remedies Recent Developments/Updates
    Table 170. Vasudha Pharma Corporation Information
    Table 171. Vasudha Pharma Description and Business Overview
    Table 172. Vasudha Pharma Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 173. Vasudha Pharma Olmesartan API Product
    Table 174. Vasudha Pharma Recent Developments/Updates
    Table 175. Macleods Pharmaceuticals Corporation Information
    Table 176. Macleods Pharmaceuticals Description and Business Overview
    Table 177. Macleods Pharmaceuticals Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 178. Macleods Pharmaceuticals Olmesartan API Product
    Table 179. Macleods Pharmaceuticals Recent Developments/Updates
    Table 180. Mylan Corporation Information
    Table 181. Mylan Description and Business Overview
    Table 182. Mylan Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 183. Mylan Olmesartan API Product
    Table 184. Mylan Recent Developments/Updates
    Table 185. Key Raw Materials Lists
    Table 186. Raw Materials Key Suppliers Lists
    Table 187. Olmesartan API Distributors List
    Table 188. Olmesartan API Customers List
    Table 189. Olmesartan API Market Trends
    Table 190. Olmesartan API Market Drivers
    Table 191. Olmesartan API Market Challenges
    Table 192. Olmesartan API Market Restraints
    Table 193. Research Programs/Design for This Report
    Table 194. Key Data Information from Secondary Sources
    Table 195. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Olmesartan API
    Figure 2. Global Olmesartan API Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Olmesartan API Market Share by Type in 2023 & 2030
    Figure 4. Purity 99% Product Picture
    Figure 5. Purity > 99% Product Picture
    Figure 6. Global Olmesartan API Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Olmesartan API Market Share by Application in 2023 & 2030
    Figure 8. Tablet Products
    Figure 9. Capsule Products
    Figure 10. Others
    Figure 11. Global Olmesartan API Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Olmesartan API Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Olmesartan API Sales (2019-2030) & (Tons)
    Figure 14. Global Olmesartan API Average Price (US$/Kg) & (2019-2030)
    Figure 15. Olmesartan API Report Years Considered
    Figure 16. Olmesartan API Sales Share by Manufacturers in 2023
    Figure 17. Global Olmesartan API Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Olmesartan API Players: Market Share by Revenue in 2023
    Figure 19. Olmesartan API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Olmesartan API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Olmesartan API Sales Market Share by Country (2019-2030)
    Figure 22. North America Olmesartan API Revenue Market Share by Country (2019-2030)
    Figure 23. U.S. Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Olmesartan API Sales Market Share by Country (2019-2030)
    Figure 26. Europe Olmesartan API Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Olmesartan API Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Olmesartan API Revenue Market Share by Region (2019-2030)
    Figure 34. China Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Taiwan Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Philippines Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Olmesartan API Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Olmesartan API Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Olmesartan API Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Olmesartan API Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. U.A.E Olmesartan API Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Olmesartan API by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Olmesartan API by Type (2019-2030)
    Figure 56. Global Olmesartan API Price (US$/Kg) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Olmesartan API by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Olmesartan API by Application (2019-2030)
    Figure 59. Global Olmesartan API Price (US$/Kg) by Application (2019-2030)
    Figure 60. Olmesartan API Value Chain
    Figure 61. Olmesartan API Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Drugs to Treat Hypertriglyceridemia - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37P13132
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Pseudobulbar Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-11M17013
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Medications for Canine Atopic Dermatitis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-13T13744
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Medications for Actinic Keratosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-36R13742
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions